MEHA on OTC
Functional Brands Inc.
Our principal business is the production, marketing, sales, and distribution of nutraceutical products through our Kirkman division.3 From its latest annual report
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with HEALTHY EXTRACTS INC., Target Group Inc. or FITLIFE BRANDS, INC., or pick any stock.
- TickerMEHA on OTC1
- IndustryMedicinal Chemicals & Botanical Products1
- HeadquartersWest Hollywood, California1
- Incorporated inDE2
- Business address8605 Santa Monica Blvd, West Hollywood, Ca 900692
- Filer category, Emerging growth company2
- Legal formCorporation
See how the biggest companies compare on our leaderboards
Our principal business is the production, marketing, sales, and distribution of nutraceutical products through our Kirkman division.3 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
52.7%Gross margin4
-21.2%Operating margin4
11.5%Net margin4
0.7%Revenue growth, 20254
49.2%Return on equity4
0.09×Debt to equity4
-$1.3MFree cash flow4
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Nutraceuticalsupplements brought in 98% of the revenue Functional Brands Inc. broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2024 | 2025 |
|---|---|---|
| Nutraceuticalsupplements | $6.4M | $6.5M |
| Hemp Derived Products | $128.5K | $124.6K |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue47¢$3.1M
- Other costs41¢$2.7M
- Profit11¢$758.5K
Out of $6.6M in revenue.4
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenue, net of returns | $6.6M | $6.6M |
| Cost of goods sold | $3.1M | $3.0M |
| Gross profit | $3.5M | $3.6M |
| Sales and marketing | $632.4K | $576.3K |
| General and administrative expenses | $4.3M | $3.3M |
| Total operating expenses | $4.9M | $3.8M |
| Operating loss | -$1.4M | -$229.1K |
| Interest expense | -$402.4K | -$331.8K |
| Other income ERTC refund | $419.9K | |
| Other income | $112 | |
| Interest income | $74.7K | $1.6K |
| Change in fair value of derivative liabilities | $7.4M | |
| Loss on issuance of preferred stock derivative liability | -$5.3M | |
| Total other income / (expenses) | $2.2M | -$330.3K |
| Net income / (loss) | $758.5K | -$559.4K |
| Basic (in Dollars per share) | $0.08 | -$0.08 |
| Diluted (in Dollars per share) | $0.01 | -$0.08 |
| Basic (in Shares) | 8.2M shares | 6.7M shares |
| Diluted (in Shares) | 85.1M shares | 6.7M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 5 fiscal years (annual) or 6 quarters (quarterly), latest first.4
| Period ending | 2025-12-31 | 2025-01-31 | 2024-12-31 | 2023-12-31 | 2023-08-31 |
|---|---|---|---|---|---|
| Cash | $2.7M | $211.6K | |||
| Accounts receivable, net | $518.5K | $303.5K | |||
| Inventories, net | $1.5M | $1.7M | |||
| Prepaid expenses and other current assets | $393.0K | $45.1K | |||
| Deferred offering costs | $588.6K | ||||
| Total current assets | $5.2M | $2.9M | |||
| Property and equipment, net | $37.4K | $49.6K | |||
| Right-of-use assets, net | $1.7M | $2.0M | |||
| Intangible assets, net | $1.4M | $1.4M | |||
| Goodwill | $818.1K | $818.1K | |||
| Total non-current assets | $3.9M | $4.3M | |||
| Total assets | $9.1M | $7.2M | |||
| Accounts payable and accrued liabilities | $1.6M | $2.0M | |||
| Line of credit | $8.1K | $32.2K | |||
| SBA loan, current | $3.6K | $3.4K | |||
| Lease liabilities, current | $371.3K | $291.2K | |||
| Other current liabilities | $41.8K | $35.3K | |||
| Derivative liabilities | $3.3M | ||||
| Payable for acquisition, current | $2.3M | ||||
| Loans payable (related party), current | $61.6K | $370.7K | |||
| Loans payable | $402.6K | $171.5K | |||
| Total current liabilities | $5.8M | $5.2M | |||
| Lease liabilities, net of current | $1.4M | $1.8M | |||
| SBA loan, net of current | $136.9K | $140.5K | |||
| Loan payable (related party), net of current | $244.5K | ||||
| Convertible debenture | $100.0K | ||||
| Total non-current liabilities | $1.8M | $2.1M | |||
| Total liabilities | $7.6M | $7.3M | |||
| Common stock, par value $0.00001, 220,000,000 shares authorized; 18,704,649 and 6,694,880 shares issued and outstanding at December 31, 2025 and 2024 | $187 | $67 | |||
| Additional paid-in capital | $8.5M | $7.5M | |||
| Accumulated deficit | -$7.0M | -$7.7M | |||
| Total stockholders equity / (deficit) | $1.5M | -$118.6K | $25.9K | ||
| Total liabilities and stockholders equity / (deficit) | $9.1M | $7.2M | |||
| Preferred stock, par value (in Dollars per share) | $0.00 | ||||
| Preferred stock, shares authorized (in Shares) | 1.0M shares | ||||
| Common stock, par value (in Dollars per share) | $0.00 | $0.00 | $0.00 | ||
| Common stock, shares authorized (in Shares) | 220.0M shares | 220.0M shares | 220.0M shares | ||
| Common stock, shares issued (in Shares) | 18.7M shares | 6.7M shares | |||
| Common stock, shares outstanding (in Shares) | 18.7M shares | 6.7M shares |
| Period ending | 2025-12-31 | 2025-01-31 | 2024-12-31 | 2023-12-31 | 2023-08-31 | 2020-11-30 |
|---|---|---|---|---|---|---|
| Cash | $2.7M | $211.6K | ||||
| Accounts receivable, net | $518.5K | $303.5K | ||||
| Inventories, net | $1.5M | $1.7M | ||||
| Prepaid expenses and other current assets | $393.0K | $45.1K | ||||
| Deferred offering costs | $588.6K | |||||
| Total current assets | $5.2M | $2.9M | ||||
| Property and equipment, net | $37.4K | $49.6K | ||||
| Right-of-use assets, net | $1.7M | $2.0M | ||||
| Intangible assets, net | $1.4M | $1.4M | ||||
| Goodwill | $818.1K | $818.1K | ||||
| Total non-current assets | $3.9M | $4.3M | ||||
| Total assets | $9.1M | $7.2M | ||||
| Accounts payable and accrued liabilities | $1.6M | $2.0M | ||||
| Line of credit | $8.1K | $32.2K | ||||
| SBA loan, current | $3.6K | $3.4K | ||||
| Lease liabilities, current | $371.3K | $291.2K | ||||
| Other current liabilities | $41.8K | $35.3K | ||||
| Derivative liabilities | $3.3M | |||||
| Payable for acquisition, current | $2.3M | |||||
| Loans payable (related party), current | $61.6K | $370.7K | ||||
| Loans payable | $402.6K | $171.5K | ||||
| Total current liabilities | $5.8M | $5.2M | ||||
| Lease liabilities, net of current | $1.4M | $1.8M | ||||
| SBA loan, net of current | $136.9K | $140.5K | ||||
| Loan payable (related party), net of current | $244.5K | |||||
| Convertible debenture | $100.0K | |||||
| Total non-current liabilities | $1.8M | $2.1M | ||||
| Total liabilities | $7.6M | $7.3M | ||||
| Common stock, par value $0.00001, 220,000,000 shares authorized; 18,704,649 and 6,694,880 shares issued and outstanding at December 31, 2025 and 2024 | $187 | $67 | ||||
| Additional paid-in capital | $8.5M | $7.5M | ||||
| Accumulated deficit | -$7.0M | -$7.7M | ||||
| Total stockholders equity / (deficit) | $1.5M | -$118.6K | $25.9K | |||
| Total liabilities and stockholders equity / (deficit) | $9.1M | $7.2M | ||||
| Preferred stock, par value (in Dollars per share) | $0.00 | |||||
| Preferred stock, shares authorized (in Shares) | 1.0M shares | |||||
| Common stock, par value (in Dollars per share) | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Common stock, shares authorized (in Shares) | 220.0M shares | 220.0M shares | 220.0M shares | 100.0M shares | ||
| Common stock, shares issued (in Shares) | 18.7M shares | 6.7M shares | ||||
| Common stock, shares outstanding (in Shares) | 18.7M shares | 6.7M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net income (loss) | $758.5K | -$559.4K |
| Allowance for doubtful accounts receivable | -$3.8K | -$32.5K |
| Allowance for inventory obsolescence | $53.9K | -$14.2K |
| Depreciation of property and equipment | $20.7K | $48.4K |
| Amortization of right-of-use assets | $332.4K | $306.9K |
| Amortization of intangible assets | $46.1K | $46.1K |
| Financing expense on warrant issuance | $45.4K | |
| Stock-based compensation | $543.1K | $414.9K |
| Change in fair value of derivative liabilities | -$7.4M | |
| Loss on issuance of preferred stock of derivative liabilities | $5.3M | |
| Issuance of shares for note extension | $80.5K | |
| Issuance of common stock for convertible debenture | $122.3K | |
| Issuance of shares for financing expense | $50.6K | |
| Accounts receivable | -$211.2K | -$100.0K |
| Inventories | $106.1K | -$1.2K |
| Prepaid expenses and other current assets | -$347.9K | $27.3K |
| Accounts payable and accrued liabilities | -$480.8K | $132.2K |
| Other current liabilities | $6.5K | -$5.5K |
| Lease liabilities | -$329.3K | -$261.0K |
| Net cash (used in) provided by operating activities | -$1.3M | $2.0K |
| Purchase of property and equipment | -$8.5K | -$1.9K |
| Net cash used in investing activities: | -$8.5K | -$1.9K |
| Deferred offering costs | -$1.7M | -$163.1K |
| Proceeds from loans | $489.3K | $301.5K |
| Payments for payable for acquisition | -$2.3M | -$255.0K |
| Proceeds from debt facilities | $99.7K | $180.7K |
| Repayment of loans | -$422.7K | -$6.9K |
| Proceeds from issuance of preferred stock | $8.0M | |
| Buyback of preferred stock | -$180.3K | |
| Line of credit repayment | -$123.9K | -$216.7K |
| SBA loan repayment | -$3.4K | -$3.3K |
| Net cash provided by (used in) financing activities | $3.8M | -$162.9K |
| Increase (decrease) in cash | $2.5M | -$162.8K |
| Cash paid for interest | $401.4K | $224.4K |
| Recognition of derivative liability of preferred stock | $13.3M | |
| Conversion of preferred stock resulting in a non-cash reduction of the derivative liability recorded to APIC | $2.6M | |
| Fair value adjustment decreasing derivative liability | $7.4M | |
| Change in Preferred Stock | $115 | |
| Conversion of preferred stock | $112 | |
| Deferred offering costs | -$2.3M | |
| Declaration of preferred stock dividend recorded as an increase in accrued liabilities | $78.9K | |
| Common stock issued for convertible note payable and accrued interest | $122.3K | |
| Loan payable, related party | $225.0K |
No quarter-by-quarter statement was filed.
Leadership
Who has led Functional Brands Inc., and when. Pick a name to see everywhere that person has worked.
- Chief executive officerEric Jon Gripentrog Dec 4, 2025 to now7
- Chief financial officerDavid R. Wells May 20, 2026 to now8
Board members and other officers (3)
- Board memberDavid R. Wells May 20, 2026 to now8
- Board memberEric Jon Gripentrog Dec 4, 2025 to now7
- Board memberLourdes Felix Dec 4, 2025 to now9
Named in SEC Form D filings
People the company listed in its private-offering notices.
- Executive Officer, DirectorTariq Rahim named Apr 22, 2022 to Nov 10, 202510
- Executive OfficerDiana Mark named Apr 22, 202211
- Executive Officer, DirectorZayn Kalyan named Apr 22, 202211
- DirectorGirard Smith named Nov 10, 202510
- DirectorSteven Rossi named Nov 10, 202510
- DirectorMichael Townsend named Apr 22, 202211
- DirectorRichard Kurtz named Apr 22, 202211
Former names
- HT Naturals Corp.Dec 28, 2020 to May 2, 20232
Timeline
- Dec 4, 2025New chief executive Eric Jon Gripentrog becomes CEO7
Filings
107 filings to the SEC since October 2021: 1 annual reports, 3 quarterly reports, 23 major events, 3 insider forms, 3 large holders, 3 private raises, 71 other. The latest 20:
- Aug 17, 20268-K CURRENT REPORT EDGAR
- Aug 14, 202610-Q QUARTERLY REPORT EDGAR
- Jul 13, 202625-NSE EDGAR
- Jul 2, 20268-K CURRENT REPORT EDGAR
- Jul 1, 20268-K CURRENT REPORT EDGAR
- Jun 15, 20268-K CURRENT REPORT EDGAR
- Jun 2, 20268-K CURRENT REPORT EDGAR
- May 28, 20268-K CURRENT REPORT EDGAR
- May 27, 2026DEFA14A DEFINITIVE ADDITIONAL MATERIALS EDGAR
- May 27, 2026DEFA14A DEFINITIVE ADDITIONAL MATERIALS EDGAR
- May 22, 20268-K/A AMENDMENT NO.1 TO FORM 8-K EDGAR
- May 22, 20268-K CURRENT REPORT EDGAR
- May 21, 2026DEFA14A DEFINITIVE ADDITIONAL MATERIALS EDGAR
- May 20, 20263 EDGAR
- May 20, 20268-K CURRENT REPORT EDGAR
- May 19, 2026DEFA14A CURRENT REPORT EDGAR
- May 19, 20268-K CURRENT REPORT EDGAR
- May 19, 2026DEFA14A DEFINITIVE ADDITIONAL MATERIALS EDGAR
- May 19, 2026SCHEDULE 13G/A EDGAR
- May 18, 20268-K CURRENT REPORT EDGAR
The 107 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Helena Global Investment Opportunities 1 Ltd.SCHEDULE 13G/A, 2 filings May 14, 2026 to May 19, 202612
- Leonite Fund I, LPSCHEDULE 13G, 1 filing May 13, 202613
Money raised
Private offerings the company reported to the SEC on Form D.
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| Guardian Partners Inc. | 38,972 | $203 | 0.0% | New |
13F reports cover disclosed long positions in U.S. stocks only.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9SEC EDGARLourdes Felix, Board member
- 10
- 11
- 12
- 13